Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 10000
Country/Region: Vietnam
Year: 2015
Main Partner: Harvard University
Main Partner Program: Harvard Medical School (Harvard Medical School AIDS Initiative in Vietnam)
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $1,117,700 Additional Pipeline Funding: $241,341

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $268,659
Treatment: Adult Treatment (HTXS) $761,542
Treatment: Pediatric Treatment (PDTX) $87,499
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 249
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 269
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 9,326
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 16,600
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 26,444
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 26,444
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 26,444
TX_CURR Aggregated Age/Sex: <1 Female 2016 5
TX_CURR Aggregated Age/Sex: <1 Male 2016 2
TX_CURR Aggregated Age/Sex: 15+ Female 2016 8,941
TX_CURR Aggregated Age/Sex: 15+ Male 2016 15,737
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 25,153
TX_CURR Sum of Aggregated Age/Sex (<1 and 1-14) <15 2016 475
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 24,678
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 24,678
Cross Cutting Budget Categories and Known Amounts Total: $1
Human Resources for Health $1